Paolo Tarantino: How do SONIA and NATALEE impact our use of CDK4/6-inhibitors – OncoDaily
Paolo Tarantino: How do SONIA and NATALEE impact our use of CDK4/6-inhibitors / Albert Grinshpun, cancer, OncoDaily, Oncology, Paolo Tarantino, Ribociclib
Paolo Tarantino: How do SONIA and NATALEE impact our use of CDK4/6-inhibitors / Albert Grinshpun, cancer, OncoDaily, Oncology, Paolo Tarantino, Ribociclib
Phase II trial misses main goal, but drugmaker set to forge ahead
Wafik El-Deiry: Great research planning meeting with Dr. Benedito Carneiro / Benedito A. Carneiro, Brown University Legorreta Cancer Center, cancer, Cancer
Esophageal Squamous Cell Carcinoma (ESCC) accounts for a significant portion of esophageal cancer cases worldwide, particularly in high-risk regions like China,…
Redes sociales:https://www.instagram.com/realidadmedicapodcast/https://www.tiktok.com/@UCEQjj1nhbeoPwFyX8I-bxHg
View the current volume of the ASCO Educational Book
To present an application of specification curve analysis—a novel analytic method that involves defining and implementing all plausible and valid analytic approaches for addressing a…
This cross-sectional study assesses the association of use of labor neuraxial analgesia for vaginal delivery with severe maternal morbidity.
Robert Michael Daly Memorial Sloan Kettering Cancer Center, New York, NY Robert Michael Daly, Karolina Bryl, Raymond E Baser, Angela Green, Tony Hung, Erin F.…
Ravi Gupta and colleagues argue that we need to reconsider standards for targeted pharmaceutical marketing to doctors through speaker programmes, consulting programmes, and advisory board…
Saurabh Zanwar Division of Hematology, Mayo Clinic, Rochester, MN Saurabh Zanwar, Surbhi Sidana, Leyla Shune, Omar Alexis Castaneda Puglianini, Oren Pasvolsky, Rebecca Gonzalez, Danai Dima,…